spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Pharmaceutical and Medical Industry Increasingly Demands Automated Testing Solutions

ZwickRoell


After the manufacturing processes in pharmaceutical and medical industries reached a high level of automation in recent years, manufacturers are more committed to automating their testing processes as well. Production-related tests as well as tests for product release are to be largely automated. In addition to higher specimen throughput, an increase in reproducibility through the elimination of operator influence is a main objective for manufacturers. Zwick Roell offers various levels of automation for testing syringes, insulin pens, and auto injectors.

The market for pre-filled syringes is growing steadily. This development is reflected in the growth of biological and complex active ingredients as well as in the increasing requirements of patients and nursing staff. Experts estimate that this market will double to approximately 6 million units by 2024.* The increasing production numbers also affect quality control. The pharmaceutical industry is increasingly looking for reliable testing solutions that are also economical.

Zwick Roell offers a special test fixture in conjunction with a semi-automatic feeding system for testing such pre-filled syringes. This test fixture is used to determine the breakaway force and glide force of syringes, syringe cartridges, and similar dosimeters. The test is based on the following standards: DIN EN ISO 7886 -1, DIN EN ISO 11499 and ISO 11040-4. The breakaway force and glide force are important parameters used to select the most suitable syringe. These forces may not exceed or fall below certain limits to ensure that a safe drug dose is administered. In addition to the friction in the syringe, the forces are influenced by the viscosity of the drug and the size of the cannula. To reducer operator influence (MSA 3/Gauge R&R Type 3) when simultaneously increasing the clock frequency, the test fixture can be combined with a semi-automatic feeding system. This rotation magazine holds up to 15 syringes and isversatile since the fixture can be used for various syringe diameters. By using a second rotation magazine on the the same machine, the cap removal force can also be determined before the glide force.

The test is controlled and evaluated via the testXpert III software, enabling all requirements of the expanded Traceability to be met according to FDA 21Part 11. The testing system can also be equipped with a precision scale that can be used to determine the escaping drug amounts in addition to the breakaway/glide force. To support the validation of the testing machine, Zwick can perform a complete qualification (DQ/IQ/OQ).
phone +49 7305 100
email info@zwick.com
web www.zwick.com/medical
email August-Nagel-Strasse 11, 89079, ULM, Germany
 
Print this page
Send to a friend
   
spacer
News and Press Releases

PCI Pharma Services Announces Bottling Line Expansion to Support Customer Needs

Philadelphia, USA – February 5, 2019 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, is pleased to announce the expansion of its bottling line capacity at its Commercial Packaging site in Rockford, IL. Construction of the additional packaging suites began in March 2018 to add considerable footprint for primary and secondary packaging operations equipped with high speed tablet filling, cartoning, as well as in-line serialization and aggregation in support of increased customer demand. The new expansion will grow the robust bottling operation in Rockford by producing an extra 100 million bottles per year.
More info >>


White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement